Furthermore, deficiency of CCR5 (the receptor for CCL5, a chemokine also known as RANTES) in ApoE-/- mice does not appear to be protective in the early stages of atherosclerosis [72]. This evidence concerns the gene CCL5 and atherosclerosis.